Twenty years of research in melanoma therapy-From "nothing works" to cures: A personal account
- PMID: 37726985
- PMCID: PMC11187729
- DOI: 10.1111/pcmr.13133
Twenty years of research in melanoma therapy-From "nothing works" to cures: A personal account
Keywords: BRAF; checkpoint inhibitors; collaboration; therapy.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURE
No conflicts of interest.
References
-
- Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002). Mutations of the BRAF gene in human cancer. Nature, 417(6892):949–54. doi: 10.1038/nature00766 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials